Status:
WITHDRAWN
Performances of DendrisCHIP®OA in Bone and Joint Infections
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Bone Infection
Joint Infection
Eligibility:
All Genders
18+ years
Brief Summary
Bone and joint infections (BJI) with and without prosthetic material (knee, hip and shoulder) are complex to diagnose and treat, justifying the creation of expert centers by the French Ministry of Hea...
Detailed Description
Bone and joint infections (BJI) with and without prosthetic material (knee, hip and shoulder) are complex to diagnose and treat, justifying the creation of expert centers by the French Ministry of Hea...
Eligibility Criteria
Inclusion
- Patients aged ⩾ 18 years,
- Patients suspected of bone and joint infection,
- Any patient who had intraoperative samples for suspected BJI with or without material, and who received on broad-spectrum antibiotic therapy post-operatively,
- No opposition from the patient, or its surrounding.
Exclusion
- Refusal to participate,
- Pregnant or beastfeeding,
- Patient under guardianship or curatorship,
- Patient not affiliated to social security,
- Patient affiliated to the Aide Médicale d'Etat (AME).
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06132347
Start Date
December 1 2023
End Date
May 1 2024
Last Update
June 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.